Jubilant Pharmova (BOM:530019) YoY EBITDA Growth : -49.31% (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Jubilant Pharmova's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -49.31%.

Jubilant Pharmova's EBITDA per Share for the three months ended in Mar. 2024 was ₹7.62.

Jubilant Pharmova YoY EBITDA Growth Historical Data

The historical data trend for Jubilant Pharmova's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova YoY EBITDA Growth Chart

Jubilant Pharmova Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

9.92

-10.04

-23.06

-33.11

7.53

Jubilant Pharmova Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															0.27	-13.64	51.50	73.81	-49.31

Jubilant Pharmova YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Jubilant Pharmova's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(51.985	-	48.346)	/	\| 48.346 \|
=	7.53 %

Jubilant Pharmova's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(7.62	-	15.032)	/	\| 15.032 \|
=	-49.31 %

Jubilant Pharmova YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Jubilant Pharmova (BOM:530019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

JUBLPHARMA:India

Address

1A, Sector 16A, Noida, UP, IND, 201 301

Website

https://www.jubilantpharmova.com

Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova (BOM:530019) Headlines

No Headlines